英文名稱 | ABT-494(Upadacitinib) Free base |
---|---|
中文名稱 | 烏帕替尼 |
CAS號(hào) | 1310726-60-3 |
分子式 | C??H??F?N?O |
分子量 | 380.37 |
外觀 | White to yellow powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無(wú)牌價(jià)信息,您可以發(fā)送詢價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱 | ABT-494(Upadacitinib) Free base |
---|---|
中文名稱 | 烏帕替尼 |
CAS號(hào) | 1310726-60-3 |
分子式 | C??H??F?N?O |
分子量 | 380.37 |
外觀 | White to yellow powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Upadacitinib, also known as ABT-494, is a potent and selective JAK inhibitors in development for rheumatoid arthritis. ABT-494 is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. ABT-494 demonstrates efficacy in rat arthritis models. Preliminary evidence suggests that compared to tofacitinib, ABT-494 may spare Jak2 and Jak3 dependent signaling.